134 related articles for article (PubMed ID: 7740511)
1. Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Ueno Y; Kawashima A; Koike H; Nishio S
Thromb Res; 1995 Jan; 77(2):193-8. PubMed ID: 7740511
[No Abstract] [Full Text] [Related]
2. [Effect of danshen injection on pulmonary thromboembolism and platelet free radical levels in mice].
Wang X; Pang J; Shan C; Yang S; Zheng Y
Zhongguo Zhong Yao Za Zhi; 1996 Sep; 21(9):558-60, inside back cover. PubMed ID: 9772649
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
[TBL] [Abstract][Full Text] [Related]
4. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation.
Maurin N
Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582
[No Abstract] [Full Text] [Related]
6. PEP trial. Pulmonary Embolism Prevention.
Cimminiello C
Lancet; 2000 Jul; 356(9225):247-8; author reply 250-1. PubMed ID: 10963216
[No Abstract] [Full Text] [Related]
7. The anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolism.
Uckun FM; Vassilev A; Bartell S; Zheng Y; Mahajan S; Tibbles HE
Leuk Lymphoma; 2003 Sep; 44(9):1569-77. PubMed ID: 14565661
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic Activity of a New Hypoglycemic Compound Limiglidole in Mouse Model of Cell Thrombosis.
Kucheryavenko AF; Spasov AA; Smirnov AV
Bull Exp Biol Med; 2015 May; 159(1):41-3. PubMed ID: 26033587
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
Nishio S; Kurumatani H
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Foeniculum vulgare essential oil and anethole in an experimental model of thrombosis.
Tognolini M; Ballabeni V; Bertoni S; Bruni R; Impicciatore M; Barocelli E
Pharmacol Res; 2007 Sep; 56(3):254-60. PubMed ID: 17709257
[TBL] [Abstract][Full Text] [Related]
11. [Oral administration of beraprost sodium did not exacerbate pulmonary hypertension with CREST syndrome].
Furukawa K; Ikeda S; Obase K; Muroya T; Oka H; Kojima M; Miyahara Y; Kohno S
Nihon Naika Gakkai Zasshi; 2001 May; 90(5):881-3. PubMed ID: 11460359
[No Abstract] [Full Text] [Related]
12. Antithrombotic effects of tetramethylpyrazine in in vivo experiments.
Sheu JR; Hsiao G; Lee YM; Yen MH
Int J Hematol; 2001 Apr; 73(3):393-8. PubMed ID: 11345210
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Tamura M; Kurumatani H; Matsushita T
Prostaglandins Leukot Essent Fatty Acids; 2001 Mar; 64(3):197-202. PubMed ID: 11334556
[TBL] [Abstract][Full Text] [Related]
14. Orally active prostacyclin analogue for cardiovascular disease.
Nagaya N
Int Angiol; 2010 Apr; 29(2 Suppl):14-8. PubMed ID: 20357744
[TBL] [Abstract][Full Text] [Related]
15. Beraprost therapy for pulmonary arterial hypertension.
Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of beraprost sodium, a stable analogue of PGI2, and its mechanisms.
Ueno Y; Koike H; Annoh S; Nishio S
Prostaglandins; 1997 Apr; 53(4):279-89. PubMed ID: 9167214
[TBL] [Abstract][Full Text] [Related]
17. Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction.
Gebalska J; Wolk R; Ceremuzynski L
Clin Cardiol; 2000 Nov; 23(11):837-41. PubMed ID: 11097131
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
Miyata M; Ueno Y; Sekine H; Ito O; Sakuma F; Koike H; Nishio S; Nishimaki T; Kasukawa R
J Cardiovasc Pharmacol; 1996 Jan; 27(1):20-6. PubMed ID: 8656653
[TBL] [Abstract][Full Text] [Related]
19. Beneficial action of beraprost sodium, a prostacyclin analog, in stroke-prone rats.
Stier CT; Chander PN; Belmonte A; Inamdar RS; Mistry M
J Cardiovasc Pharmacol; 1997 Sep; 30(3):285-93. PubMed ID: 9300310
[TBL] [Abstract][Full Text] [Related]
20. PEP trial. Pulmonary Embolism Prevention.
Mahé I; Bergmann JF; Mahé E; Caulin C
Lancet; 2000 Jul; 356(9225):248; author reply 250-1. PubMed ID: 10963217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
